ExAblate Blood Brain Barrier Disruption (BBBD) for Planned Surgery in Suspected Infiltrating Glioma
Clinical trial NCT03322813 · SUSPENDED
Trial details
- NCT number
- NCT03322813
- Sponsor
- InSightec
- Status
- SUSPENDED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-01
- Primary completion
- 2024-09-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.